The prevalence of Peyronie's disease in diabetic patients with erectile dysfunction

Smith BH . Peyronie's disease. Am J Clin Pathol 1966; 45: 670–678.

Sommer F, Schwarzer U, Wassmer G, Bloch W, Braun M, Klotz T et al. Epidemiology of Peyronie's disease. Int J Impot Res 2002; 14: 379–383.

Schwarzer U, Sommer F, Klotz T, Braun M, Reifenrath B, Engelmann U . The prevalence of Peyronie's disease: results of a large survey. BJU Int 2001; 88: 727–730.

Smith CJ, McMahon C, Shabsigh R . Peyronie's disease: the epidemiology, aetiology and clinical evaluation of deformity. BJU Int 2005; 95: 729–732.

Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB . Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54–61.

Rendell MS, Rajfer J, Wicker PA, Smith MD . Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study Group. JAMA 281; 421: 1999.

El-Sakka AI, Tayeb KA . Peyronie's disease in diabetic patients being screened for erectile dysfunction. J Urol 2005; 174: 1026–1030.

Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BM . Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999; 11: 319–326.

Mulhall JP . Expanding the paradigm for plaque development in Peyronie's disease. Int J Impot Res 2003; 15 (Suppl 5): S93–S102.

Tefekli A, Kandirali E, Erol B, Tunc M, Kadioglu A . Peyronie's disease: a silent consequence of diabetes mellitus. Asian J Androl 2006; 8: 75–79.

Chew KK, Stuckey BG, Earle CM, Dhaliwal SS, Keogh EJ . Penile fibrosis in intracavernosal prostaglandin E1 injection therapy for erectile dysfunction. Int J Impot Res 1997; 9: 225–229.

Lopez JA, Jarow JP . Duplex ultrasound findings in men with Peyronie's disease. Urol Radiol 1991; 12: 199–202.

Rhoden EL, Teloken C, Ting HY, Lucas ML, Teodosio da Ros C, Ary Vargas Souto C . Prevalence of Peyronie's disease in men over 50-y-old from Southern Brazil. Int J Impot Res 2001; 13: 291–293.

La Pera G, Pescatori ES, Calabrese M, Boffini A, Colombo F, Andriani E et al. Peyronie's disease: prevalence and association with cigarette smoking. A multicenter population-based study in men aged 50–69 years. Eur Urol 2001; 40: 525–530.

Levine LA, Coogan CL . Penile vascular assessment using color duplex sonography in men with Peyronie's disease. J Urol 1996; 155: 1270–1273.

Usta MF, Bivalacqua TJ, Tokatli ZR, Rivera F, Gulkesen K, Sikka S et al. Stratification of penile vascular pathologies in patients with Peyronie's disease and in men with erectile dysfunction according to age: a comparative study. J Urol 2004; 172: 259–262.